Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Prostatic Neoplasms × Neoadjuvant Therapy × Clear all

Phase

Phase 2 6 Phase 3 2 Phase NA 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 12 Rectal Neoplasms 6 Colorectal Neoplasms 4 Neoplasms 3 Carcinoma, Intraductal, Noninfiltrating 3 Urinary Bladder Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Esophageal Neoplasms 2 Breast Carcinoma In Situ 2 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Rhabdoid Tumor 1 Prostatic Neoplasms 1 Peritoneal Metastases From Gastric Cancer 1 Peritoneal Metastases From Colorectal Cancer 1 Osteosarcoma 1 Neuroblastoma 1 Neoplasm, Residual 1 Mesothelioma, Malignant 1 Malignant Tumor of Lacrimal Drainage Structure 1 Lung Neoplasms 1 Locally Advanced Rectal Carcinoma 1 Locally Advanced Breast Cancer 1 Kidney Neoplasms 1 Irritable Bowel Syndrome 1 High-Risk Cancer 1 Glioblastoma 1 Endometrial Neoplasms 1

Interventions

Radiosurgery 38 Magnetic Resonance Spectroscopy 33 Radiotherapy 25 Standard of Care 24 Exercise 24 Brachytherapy 19 Early Intervention, Educational 18 Magnetic Resonance Imaging 15 Surveys and Questionnaires 14 Androgen Antagonists 14 Interviews as Topic 13 Blood Specimen Collection 12 Multiparametric Magnetic Resonance Imaging 11 Methods 11 Biopsy 11 Specimen Handling 10 Radiotherapy, Intensity-Modulated 10 Psychiatric Rehabilitation 10 Prostatectomy 9 Educational Status 9 Therapeutics 8 Resistance Training 8 Radiation 7 Practice Guidelines as Topic 7 Diet Therapy 7 Acupuncture Therapy 7 gallium 68 PSMA-11 6 bicalutamide 6 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 6 Proton Therapy 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04049747 2025-03-24

IP4-CHRONOS

Imperial College London

Phase NA Completed

100 enrolled 23 charts

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡